Industry news

• Antimonopoly Service: Prices for hundreds of drugs dropped by 16% in 2024

  24 January 2025 GxP news

  In 2024, the Federal Antimonopoly Service (FAS) successfully lowered the prices of 820 medications across 95 international nonproprietary names (INN). Their cost decreased by an average of 16%, the press service of the agency reported.

• Early-phase ATMP clinical trials see promising growth

  24 January 2025 Catherine Eckford / European Pharmaceutical Review

  Cell and Gene Therapy Catapult’s (CGT Catapult) findings attest to the UK remaining “a highly attractive destination for clinical trials”.

• 17 new drugs added to the list of vital and essential drugs

  23 January 2025 GxP news

  Russian Prime Minister Mikhail Mishustin has signed an order to expand the list of vital and essential drugs (VED) by adding new items. These are 17 names of drugs covering a wide range of diseases.

• Sechenov University has opened its Representative Office in Hangzhou (China)

  23 January 2025 GxP news

  The opening ceremony took place on January 17. The Representative Office will serve as a hub for promoting Russian medical education, expanding opportunities for academic exchange, and fostering scientific partnerships between the two countries.

• A Moscow region manufacturer of blood collection systems is expanding its capacity

  22 January 2025 GxP news

  The Moscow Region enterprise Granat Bio Tech, located in the Dubna special economic zone, has significantly increased its production capacity. The regional Ministry of Investment, Industry, and Science has reported that the annual production of vacuum systems designed for collecting biomaterial is projected to reach an impressive 210 million units.

• A biotechnology and medicine center has opened in Mordovia

  22 January 2025 GxP news

  The Center for the Development of Biotechnology and Medicine opened at Ogarev Mordovia State University on January 16, 2025. It includes a number of unique research laboratories, as well as an educational unit and a university clinic

• Long-term potential revealed for novel modifier gene therapy

  21 January 2025 Catherine Eckford / European Pharmaceutical Review

  The positive two-year findings from the Phase I/II gene therapy trial in retinitis pigmentosa reiterate the potential of mutation-agnostic therapies.

• Binnopharm Group opened an office in Vietnam

  21 January 2025 GxP news

  Binnopharm Group has opened its ninth representative office in Vietnam to enhance its international market presence. This will enable ongoing export growth, especially to other Southeast Asian countries like Indonesia, Malaysia, the Philippines, and Thailand.

• New guidance to aid cost-effectiveness analysis of new drugs

  20 January 2025 Catherine Eckford / European Pharmaceutical Review

  The report aims to support development of economic models for health technology assessment (HTA) decision making, as there has been “little change in guidance on the use of surrogate endpoints in HTA since 2018”.

• The Ministry of Health may expand its patent use powers

  20 January 2025 GxP news

  The Communist Party of the Russian Federation has proposed amendments to Article 1360 of the Civil Code, allowing departments like the Ministry of Health to use patented inventions without copyright holders’ approval for national security and public health.